You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 29, 2025

Suppliers and packagers for generic ingredient: EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

ApplicantTradenameGeneric NameDosageNDANDA/ANDASupplierPackage CodePackageMarketing Start
Boehringer Ingelheim TRIJARDY XR empagliflozin; linagliptin; metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 212614 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0380-13 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-13) 2020-04-23
Boehringer Ingelheim TRIJARDY XR empagliflozin; linagliptin; metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 212614 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0380-68 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-68) 2020-04-23
Boehringer Ingelheim TRIJARDY XR empagliflozin; linagliptin; metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 212614 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0385-77 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-77) 2020-04-23
Boehringer Ingelheim TRIJARDY XR empagliflozin; linagliptin; metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 212614 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0385-86 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-86) 2020-04-23
Boehringer Ingelheim TRIJARDY XR empagliflozin; linagliptin; metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 212614 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0385-88 1 BOTTLE in 1 CARTON (0597-0385-88) / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE 2020-04-23
>Applicant>Tradename>Generic Name>Dosage>NDA>NDA/ANDA>Supplier>Package Code>Package>Marketing Start
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing